PharmAware Blog

19/03/2009

Shahram Ahari speaks at Imperial

Filed under: PharmAware News — Merav @ 09:16 pm

Come along to hear the .. .

‘Confessions of a Drug Rep’

We will be hearing from Shahram Ahari who is a former pharmaceutical sales representative from Eli Lilly’s Neuroscience Division where he successfully sold the blockbuster drugs olanzapine (Zyprexa) and fluoxetine (Prozac) until he left the industry to pursue public health and social justice issues.

In the past 3 years, Mr. Ahari has given over 90 medical lectures nationally and internationally on topics such as global access to essential medicines, drug marketing’s impact on public health, and the drug rep - physician relationship. He has been a speaker for the AMA (American Medical Association), AMSA, IFMSA (International Federation of Medical Students) among other organizations. Mr. Ahari advises private and government institutions on policy issues related to the drug industry. He has testified before the US Senate, the House of Representatives and has served as an expert in matters of drug marketing, public health and policy. He has appeared on numerous media programs including CNBC Business Nation, ABC Worldnews, CBS Evening News, The NY Times, The LA Times, The Washington Post, Rolling Stone Magazine, National Public Radio and American Public Radio for his work on public health and drug marketing.

Mr. Ahari earned a B.A. in Biochemistry, Molecular Biology and Asian Studies from Rutgers College and has a Masters in Public Health with specialties in Infectious Disease and International Health from UC Berkeley.

Monday 23rd March @ 7pm

Seminar Room 119, SAF Building
Imperial College London, South Ken, SW7 2AZ (map attached)

Pharma’s Facebook

Filed under: International News — Merav @ 11:42 am

Like most social-networking sites, Inspire.com is a place where users talk about the most intimate details of their lives. They want advice on coping with stage III cancer or to offer encouragement to a mother deciding about life support for her premature baby. But Inspire’s nearly 100,000 users aren’t just sharing with each other (and the 62 nonprofits who partner with the site), they’re also receiving targeted information from pharmaceutical companies who use the site as a recruiting tool for drug studies.

www.newsweek.com/id/187882 10/3/9

Powered by WordPress